← All trials
NCT04443010
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2020
- Primary completion
- Oct 31, 2026
- Completion date
- Dec 31, 2026
- First posted
- Jun 23, 2020
- Last posted
- Dec 8, 2020
- Enrollment
- 226
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Philogen S.p.A.Lead sponsor
- University of ZurichOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.